PATENT CLAIM ANALYSIS

Application Number: 15944722
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["514", "561000"]

Abstract:
The present disclosure provides co-crystals of a substituted glycine compound and a co-former compound of Formula (I): compositions comprising such, and uses thereof in treating and/or reducing the risk for a neuropsychiatric disorder (e.g., schizophrenia, psychotic disorders, depressive disorders, suicidal ideation and/or behavior, obsessive compulsive disorder or Alzheimer's disease). Also provided herein are methods for preparing the co-crystals.

Claim (Index 31):
The co-crystal of  claim 30 , wherein the tartaric acid is D-tartaric acid.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 91.0
- Lexical Diversity: 1.35849
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15866303', '15430750', '14777018', '15188545', '14358606']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7862987662494352
- 35 USC 102 Novelty (BERT): 0.5663179994228627
- Combined Prediction Score: 0.764300689566778
- Mean Citation Score: 348.29133
- Max Citation Score: 476.92575
- Similarity Product: 345.0037366741151

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test